ENTRESTO Irish real-world evidence

ENTRESTO is indicated in adult patients for the treatment of symptomatic chronic heart failure with reduced ejection fraction.¹

For full safety information, please refer to the Summary of Product Characteristics.¹

Please see the below example of ENTRESTO use in the real-world setting.

Click on the links below to access individual cases.

Before looking through, please ensure you fully understand all prescribing considerations as per the Safety profile [2] page.